BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2908120)

  • 41. Physiological role and localization of cholecystokinin release in dogs.
    Konturek SJ; Tasler J; Bilski J; de Jong AJ; Jansen JB; Lamers CB
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G391-7. PubMed ID: 2870644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholinergic component in the human pancreatic secretory response to intraintestinal oleate.
    Valenzuela JE; Lamers CB; Modlin IM; Walsh JH
    Gut; 1983 Sep; 24(9):807-11. PubMed ID: 6193036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of cholecystokinin octapeptide on the pancreatic exocrine secretion in the pig.
    Cuber JC; Corring T; Levenez F; Bernard C; Chayvialle JA
    Can J Physiol Pharmacol; 1989 Nov; 67(11):1391-7. PubMed ID: 2627679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of gastric emptying is a physiological action of cholecystokinin.
    Debas HT; Farooq O; Grossman MI
    Gastroenterology; 1975 May; 68(5 Pt 1):1211-7. PubMed ID: 1126597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subtypes of muscarinic receptors in canine pancreatic secretion in vivo and in vitro.
    Konturek SJ; Jaworek J; Tasler J; Cieszkowski M; Yanaihara N
    Int J Pancreatol; 1987 Feb; 2(1):11-22. PubMed ID: 2445873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of hexamethonium and atropine on gastric secretion elicited by histamine, pentagastrin and choline esters in the dog [proceedings].
    Daly MJ; Stables R
    Agents Actions; 1979 Apr; 9(1):75-6. PubMed ID: 463703
    [No Abstract]   [Full Text] [Related]  

  • 47. Intracerebroventricular administration of cholecystokinin-8 elevates plasma pancreatic polypeptide levels in awake dogs.
    Lu QH; Greeley GH; Zhu XG; Thompson JC
    Endocrinology; 1984 Jun; 114(6):2415-7. PubMed ID: 6327247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pancreatic polypeptide inhibits pancreatic enzyme secretion via a cholinergic pathway.
    Jung G; Louie DS; Owyang C
    Am J Physiol; 1987 Nov; 253(5 Pt 1):G706-10. PubMed ID: 2446510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The responses of duodenal tension receptors in sheep to pentagastrin, cholecystokinin and some other drugs.
    Cottrell DF; Iggo A
    J Physiol; 1984 Sep; 354():477-95. PubMed ID: 6148412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence that cholecystokinin octapeptide (CCK-8) acts as a potent, full agonist on gastrin receptors for acid secretion in the isolated mouse stomach: lack of antagonism by the specific CCK antagonist asperlicin.
    Lotti VJ; Chang RS; Kling PJ; Cerino DJ
    Digestion; 1986; 35(3):170-4. PubMed ID: 3781112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro.
    Hermansen K
    Endocrinology; 1984 May; 114(5):1770-5. PubMed ID: 6143659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of cholecystokinin-octapeptide on lower esophageal sphincter.
    Behar J; Biancani P
    Gastroenterology; 1977 Jul; 73(1):57-61. PubMed ID: 863201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.
    Stubbs RS; Stabile BE
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G347-52. PubMed ID: 2858160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cholecystokinin depolarizes neurons of cat pancreatic ganglion.
    Ma RC; Szurszewski JH
    Peptides; 1996; 17(5):775-83. PubMed ID: 8844766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of cholecystokinin in intestinal phase and meal-induced pancreatic secretion.
    Dale WE; Turkelson CM; Solomon TE
    Am J Physiol; 1989 Nov; 257(5 Pt 1):G782-90. PubMed ID: 2480719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A reduced pancreatic protein secretion in response to cholecystokinin (CCK) in the obese Zucker rat correlates with a reduced receptor capacity for CCK.
    Praissman M; Izzo RS
    Endocrinology; 1986 Aug; 119(2):546-53. PubMed ID: 3015550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Action of cholecystokinin on the dog sphincter of Oddi: influence of anti-cholinergic agents.
    Pozo MJ; Salido GM; Madrid JA
    Arch Int Physiol Biochim; 1990 Dec; 98(6):353-60. PubMed ID: 1705774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CK-independent increases in pancreatic secretion induced by dietary protein in chronic BPJ-diverted rats.
    Hara H; Nishi T; Narakino H; Kasai T
    Am J Physiol; 1996 Sep; 271(3 Pt 1):G501-8. PubMed ID: 8843776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced sensitivity of pancreatic cells to cholecystokinin octapeptide in obstructive jaundice.
    Kuroda T; Shiohara E; Hanazaki K; Haba Y; Iida F
    Pancreas; 1993 Jul; 8(4):413-20. PubMed ID: 8361959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.